Nov. 9, 2023, 3 p.m. | Business Wire

AI – AI-TechPark ai-techpark.com

Investment will drive commercialization and expansion of AI-powered non-invasive diagnostic tools to help evaluate cardiovascular risk Elucid, a leading medical technology company providing physicians with AI-powered imaging analysis software to assess cardiovascular disease, today announced it has raised $80 million in Series C funding. The round was led by Elevage Medical...


The post Elucid raises $80 Mn Series C Led by Elevage Medical Technologies first appeared on AI-TechPark.

ai ai-powered analysis diagnostic disease drive expansion funding imaging investment medical physicians raises risk series series c series c funding software technologies technology tools

AI Research Scientist

@ Vara | Berlin, Germany and Remote

Data Architect

@ University of Texas at Austin | Austin, TX

Data ETL Engineer

@ University of Texas at Austin | Austin, TX

Lead GNSS Data Scientist

@ Lurra Systems | Melbourne

Senior Machine Learning Engineer (MLOps)

@ Promaton | Remote, Europe

Business Data Analyst

@ Alstom | Johannesburg, GT, ZA